Across TCGA pan-cancer cohorts, TTTY6 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated TTTY6 data layer compared with 1 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher TTTY6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TTTY6 expression acts as an unfavorable survival marker.
KIRP and SKCM are the cancer types where TTTY6 RNA most reproducibly stratifies survival.